Australia markets open in 7 hours 24 minutes

Zealand Pharma A/S (ZLDPF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
34.880.00 (0.00%)
As of 09:30AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)99.28
Price/book (mrq)14.10
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.93
52-week change 397.59%
S&P500 52-week change 3-11.09%
52-week high 334.88
52-week low 311.14
50-day moving average 330.75
200-day moving average 323.84

Share statistics

Avg vol (3-month) 3111
Avg vol (10-day) 350
Shares outstanding 551.77M
Implied shares outstanding 6N/A
Float 837.95M
% held by insiders 10.21%
% held by institutions 157.05%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in DKK.

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Dec 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-782.86%

Management effectiveness

Return on assets (ttm)-28.21%
Return on equity (ttm)-110.75%

Income statement

Revenue (ttm)103.99M
Revenue per share (ttm)2.25
Quarterly revenue growth (yoy)78.10%
Gross profit (ttm)103.99M
EBITDA -723.22M
Net income avi to common (ttm)-965.61M
Diluted EPS (ttm)-3.02
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.18B
Total cash per share (mrq)22.88
Total debt (mrq)524.08M
Total debt/equity (mrq)64.23
Current ratio (mrq)6.73
Book value per share (mrq)15.85

Cash flow statement

Operating cash flow (ttm)-942.21M
Levered free cash flow (ttm)-379.22M